Events Supposedly Attributed to Vaccine or Immunization of the AstraZeneca Vaccine: a Case Study
Published: 2023-07-06
Page: 105-109
Issue: 2023 - Volume 6 [Issue 1]
Ruvalcaba Ledezma Jesús Carlos *
Department of Medicine and Master in Public Health, Hidalgo State University, Pachuca City, Hidalgo (UAEH), Mexico.
Josefina Reynoso Vazquez
Department of Pharmacy and Masters in Public Health, Hidalgo State University, Pachuca City, Hidalgo (UAEH), Mexico.
Claudia Teresa Solano Pérez
Department of Medicine, Hidalgo State University, Pachuca City, Hidalgo (UAEH), Mexico.
Ana Erandi Montiel Hernández
Autonomous University of Nuevo León (UANL), México.
Miguel Bosco Palau Cantu
National Autonomous University of Mexico, Mexico.
María del Consuelo Cabrera Morales
Department of Medicine and Master in Public Health, Hidalgo State University, Pachuca City, Hidalgo (UAEH), Mexico.
*Author to whom correspondence should be addressed.
Abstract
A case of Events Supposedly Attributed to Vaccination or Immunization (ESAVI) due to the application of the AstraZeneca vaccine was presented on December 14th of 2021, with 14 days from beginning to resolution. It was treated with 2 administrations of Dexamethasone of 8 mg, one every 24 hours and Fexofenadine 120 mg 1 tablet every 12 hours for 7 days, stating being discharged on Tuesday 28th with vital signs within normal parameters, although wheals were slightly visible, they gradually disappeared.
Keywords: AstraZeneca, attributable, ESAVI, vaccine